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Background. Although the role of folic acid (FA) in preventing neural tube defects (NTDs) iswell documented,
its optimal intake in pregnant women is still low in many countries. Here, we prospectively studied the
prevalence of NTDs in the newborns and the patterns of FA intake in pregnant Saudi mothers.
Methods. This case–control study was nested within a 3-year project (July 2010 to June 2013) to study the
patterns of birth defects in the offspring of Saudi women who received their antenatal care and delivered at
Prince Sultan Military Medical City, Riyadh—Saudi Arabia. Enrolled mothers were divided into 4 groups: group
1 (FA taken before pregnancy and continued regularly after conception), group 2 (FA taken post-conception),
group 3 (no FA intake), and group 4 (did not remember or were unsure of taking FA). Control mothers were
randomly selected from those with normal ﬁrst obstetrical ultrasound scan at 18–22 weeks of gestation.
Results. The cohort included 30,531 mothers giving birth to 28,646 infants. We studied 1179 mothers of
babies with birth defects (BDs) and 1262 control mothers. There were 237 (9.7%) mothers in-group 1; 2001
(82%) in-group 2; 154 (6.3%) in-group 3; and 49 (2%) in-group 4. There were 49 babies with NTDs, a prevalence
of 1.7/1000 total births. Among the studied mothers 2274 (93%) took FA either full or partial course.
Conclusion. The high prevalence of NTDs and the low optimal FA intake highlight the need for a strict
implementation of staple food fortiﬁcation and health education program for Saudi women.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Neural tube defects (NTDs) include anencephaly, encephalocele,
cranial meningocele, myelomeningocele, spinal meningocele,
lipomeningocele and few other rare cerebral defects. Spina biﬁda
cystica includes spinal meningocele, myelomeningocele, myeloschisis
and lipomeningocele, and it's the most common NTDs.
Observational and interventional studies in the 1980s and 1990s
have shown that folic acid (FA) supplementation is beneﬁcial in
preventing neural tube defects (NTDs; MRC vitamin study group,
1991; Czeizel and Dudãs, 1992; Milunsky et al., 1989; Berry et al.,
1999). The most important study is the Medical Research Council
(MRC) multicentre, a randomized, double-blind trial involving 33nt fromKingAbdul Aziz City for
nal Science, Technology and
dh, Saudi Arabia.
ry Medical City, P.O. Box 7897,
, 24063.
tmail.co.uk
. This is an open access article undercenters in seven countries, studying the recurrence risk for NTDs.
A total of 1817 high-riskmothers were identiﬁed because of a previous-
ly affected pregnancy and were stratiﬁed into four groups — 1]
periconceptional use of folic acid, 2] other multivitamins with folic
acid, 3] vitamins without folic acid and 4] placebo. The study showed
that periconceptional FA supplementation had reduced the rate of
NTDs recurrence by up to 72% (MRC vitamin study group, 1991). A
study in China including more than 200,000 pregnant women showed
a protective effect of periconceptional use of FA also in low-risk
populations. (Berry et al., 1999).
Although, the exact mechanism of NTD prevention by FA remains
largely unknown, the evidence of its role in NTD prevention has come
from several sources. The epidemiological evidence is very strong
from the different populations studied using different study designs; in-
vestigators have shown that NTD risk was increased after exposure to
folate antagonist medications; and the presence of high anti-bodies
titre to folate receptors in women with a previously affected child
with NTD. Nevertheless, the use of FA supplementation in developed
and developing countries continues to be low (Vergel et al., 1990;
Brough et al., 2009).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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mends that all women planning or capable of pregnancy take a daily
supplement containing 0.4 to 0.8mg of FA (Calonge et al., 2009) starting
at least one month prior to conception and continued throughout the
ﬁrst trimester (CDC-MMWR, 1992).
In a Canadian population, DeWals et al. (2007) demonstrated a 46%
decrease in the prevalence of NTDs after full food fortiﬁcation with FA.
The decrease was greatest in geographic areas in which the baseline
NTD rate was the highest. These authors also reported a higher
reduction in the rate of spina biﬁda (53%) compared with the rate of re-
ductions in anencephaly (38%) and encephalocele (31%). A multi-state
FA grain fortiﬁcation program throughout the United States (Canﬁeld
et al., 2005) has led to an expected decrease in the prevalence of NTDs
as well as modest but statistically signiﬁcant decreases in the birth
prevalence of some non-neural tube defects like: transposition of
great arteries (12%), cleft palate only (12%), omphalocele (21%), upper
limb reduction defects (11%), and pyloric stenosis (5%).
Hospital based or community-based studies have not identiﬁed the
true prevalence of NTDs in Saudi Arabia. All the studies including the
most recent ones were retrospective analyses of only live birth cases
(Seidahmed et al, 2014). A prevalence ranging between 0.44 and 1.83/
1000 live births has been reported (Hakami and Majeed-Saidan, 2011.
Dawodu et al., 1988) where excluding stillbirths, and elective termina-
tions of pregnancy for fetal anomalies, thus, these prevalence's
represent an underestimate of true prevalence of the disease. In the
year 2000, the Grain Silos & Flour Mills Organization in Saudi Arabia
beganmandatorywheat ﬂour fortiﬁcationwith folic acid following a di-
rective from the Nutritional Administration Department of Ministry of
Health (Ministry of Health, 2000). Despite this directive, the prevalence
of NTDs remained high at 0.76/1000 live births (Safdar et al., 2007).
However, ﬂour produced by other Saudi companies and some of the
imported ﬂours packages are not marked as FA fortiﬁed. All other
grain products such as rice are not fortiﬁed with FA. This inconsistent
policy about ﬂour and other grain product fortiﬁcation with FA has led
to uncertainty about the amount of FA that Saudi women receive
through FA fortiﬁcation alone.
The prevalence of NTDs in Saudi Arabia has never been studied
prospectively, and recent publications about NTD prevalence are
contradictory (Safdar et al., 2007; Hakami and Majeed-Saidan, 2011).
Accordingly, our objectives were to study the patterns of FA use in
pregnant Saudi women who participated in the case–control study
and to prospectively determine the prevalence of NTDs. This case–
control study was nested within a 3-year research project in which we
studied the patterns of fetal and neonatal malformations in babies
born at Prince Sultan Military Medical City (PSMMC), in Riyadh—Saudi
Arabia.
Methods
Our study cohort included all babies born at Prince Sultan Military
Medical City (PSMMC) in Riyadh—Saudi Arabia over a 3-year period
(July 1, 2010 through June 30, 2013) that were studied to determine
patterns of fetal and neonatal major birth defects (BDs). A case–control
studywas nestedwithin this cohort to assess the contribution of various
confounding risk factors for BDs, including FA intake by participating
pregnant mothers.
Included mothers had their ﬁrst obstetrical ultrasound screening
examination between 18 and 22 weeks of gestation to date their preg-
nancy, detectmultiple gestations, locate theplacenta, assess the amount
of amniotic ﬂuid, and detect any fetal BDs. Mothers in the control group
were randomly selected from thosewith normal ﬁrst (at intake) obstet-
rical ultrasound scan using a computer program for their randomization
(www.random.org). All scan results were stored in the Viewpoint
computer program (GE Healthcare Viewpoint software version 5.6,
Wauwatosa, WI U.S.A) to be reviewed again when needed. Once a
major birth defect was antenatally or postnatally detected, or once themother was selected as a control, they were interviewed by one of the
authors (MSR, AMK) or a trained registrar in the department of obstet-
rics and gynecology. Parental demographic data, including parental age,
occupation, mother's weight and height, body mass index (BMI),
combined family income, and the level of maternal education was
collected for all mothers' current pregnancies. We divided pregnant
mothers into four groups based on their FA use. Group 1 (Full FA intake
group) included mothers who took FA, or one of the commercial prep-
arations that contained FA before they were pregnant and continued
to take FA (0.4 mg per day) regularly after that. Group 2 (Partial FA
Intake group) included mothers who took FA irregularly or started
taking FA postconceptionally. Group 3 (No FA intake group) included
mothers who did not take any form of FA, and group 4 (Not sure
group) included mothers who were not sure they received FA or did
not remember taking FA.
At PSMMC a trained neonatal physician examined all babies within
the ﬁrst 24 h of life. For mothers of babies with BDs, whether detected
antenatally and/or postnatally, and for mothers selected as controls,
we completed a study form that included the type of BDs and family
demographic data. Pregnancies were terminated because of NTDs and
those babies who were stillborn with NTDs were included in the NTD
prevalence calculations. However, babies with NTDs as part of a speciﬁc
recognizable syndrome were not included in the calculation of NTD
prevalence.
The collected data from these formswere reviewed by one of the in-
vestigators (MAMS) and entered into a modiﬁed version of the
EUROCAT Data Management Program (EDMP) (www.EUROCAT.com,
2005). The BDs were coded according to the WHO International
Classiﬁcation of Diseases and Related Health Problems, 10th revision
(ICD-10) with the British Paediatric Association extension (WHO, 2010).
We excluded (1) babies with major BDs that were referred to
PSMMC for further evaluation and management; (2) babies born pre-
termwith malformations related to their prematurity or a complication
such as patent ductus arteriosus (PDA) or hydrocephalus secondary to
intraventricular hemorrhage; and (3) babies who were born with only
isolated minor anomalies such as birth marks, rudimentary digits,
those without any major BDs. We also excluded mothers who had
their antenatal care outside of PSMMC and been referred for further di-
agnostic investigation or delivery (i.e., thosemotherswhowere not part
of our original cohort).
Statistical analysis
Data measured on the continuous scale were reported as mean ±
standard deviation (SD). Categorical data were reported as proportions.
Means comparisons were calculated using the independent samples
and paired samples t-tests. The association between the outcome and
potential risk factors were calculated using the chi-squared test. We
set the Type-I error rate at 5%, and used Bonferroni correction to account
for themultiplicity of testing used in our analysis (Schlesselman, 1982).
The study was approved by the Research and Ethical Committee of
the PSMMC, (project number 366, series of 2009) and funded by King
Abdul Aziz City for Science and Technology (KACST) through the
National Science, Technology and Innovation Plan (NSTIP).
Results
Cohorts and birth defects prevalence
During the study period (July 1, 2010 through June 30, 2013) there
were 28,646 births, including 28,376 live births (98.9%), 252 stillbirths
(0.9%), and 18 elective terminations of pregnancy for fetal anomalies
(0.1%). There were 2107 fetuses aborted before 20 weeks of gestation.
Of these 28,646 babies born during this 3-year period, 1262 were
classiﬁed as controls before birth and 1179 had major birth defects, a
prevalence of 41.1/1000 total births.
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Fig. 1. Distribution of mothers in the case–control cohort according to their folic acid
intake.
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Of the 2441 mothers (case–control cohort), 237 (9.7%) were in the
full FA intake group (9.2% among cases vs. 10.2% among controls),
2001 (82.0%) in partial FA intake group (79.7% vs. 84%), 154 (6.3%) in
the no FA intake group (7.5% vs. 5.2%), and 49 (2.0%) in the not sure
about FA intake group (3.6% vs. 0.5%). Fig. 1 shows the distribution of
allmothers according to their FA intake. Formothers in the full FA intake
(group 1), therewere no signiﬁcant differences between the numbers of
mothers of babies born with BDs compared with controls mothers.
However, the number of control mothers were signiﬁcantly higher in
the partial FA intake (group 2) (p b 0.006), while in the no FA intake
(group 3) and thenot suremothers (group 4), thereweremoremothersTable 1
Maternal characteristics for the case–control cohort according to their FA intake.
Characteristics Full course FA
(Group 1)a
Partial course FA
(Group 2)a
Number (%) Number (%)
237 (9.7) 2001 (82)
Mother age (years)
Mean ± SD 30.3 ± 5.9 29.7 ± 6.3
95% CI 29.6–31.1 29.4–30.0
Range 17–43 14–47
p value b0.001
Parity
Mean ± SD 2.8 ± 2.5 2.8 ± 2.6
95% CI 2.5–3.1 2.7–2.9
Range 0–12 0–16
p value b0.0001
Maternal body mass index (kg/m2)b
Number (%) 236 (9.6) 1990 (81.5)
Mean ± SD 29.3 ± 5.7 28.2 ± 6.0
95% CI 28.5–30.0 28.0–28.5
Range 17.6–49.5 14.0–54.5
p value b0.0001
a Each group includes the total number of mothers of case and control babies.
b In 16 mothers either the weight or the height were missing.
c The p-value is the summary of the test of signiﬁcance of the difference among the groups u
respect to mother's age, parity and BMI.of babies with BDs than mothers of control babies (p b 0.02 in group 3
and p b 0.001 in group 4).
Parental socioeconomic characteristics
Tables 1 and 2 show the physical and social characteristics of
parents. The ANOVA test indicated a statistically signiﬁcant deference
between the group means in general (p b 0.001). Post hoc analysis
showed that there were more mothers in groups 2 and 3 who were
young, illiterate, unemployed housewives, and whose families were
within the lowest family income category compared with groups 1
and 4.
The level of education (all grades) was signiﬁcantly higher among
mothers in group 1 (79.3%) compared with 69.4% of mothers in group
2 (p b 0.01). Thereweremore employed and/or college studentmothers
in group 1 (29.5%) compared with mothers in group 2 (20.3%). There
were 723 (29.7%) illiterate mothers; 859 (35.2%) primary school gradu-
ates; 672 (27.5%) secondary school graduates; and 187 (7.6%) university
graduates among our case–control cohort.
Outcome of affected fetuses/babies and NTD prevalence
Table 3 shows infant andmaternal characteristics for the babieswith
neural tube defects (NTDs). Group 4 (not sure of FA intake)mothers did
not give birth to any babies with NTDs and were therefore not included
in the table. The overall prevalence of isolated NTDs during the study
period was 1.7/1000 total births. Of the 49 babies with NTDs, 18
(36.7%) were males with a male:female ratio of 1/1.7. Anencephaly
was diagnosed in 25 fetuses or babies (0.9/1000 total birth) and 24
babies had spina biﬁda (0.8/1000 total birth). Among cases with anen-
cephaly, there were 7 (28%) live births, 11 (44%) terminations, and 7
(28%) fetal deaths. Among spina biﬁda cases, 21 (87.5%) were live
births, 2 (8.3%) were terminated and 1 (4.2%) was a fetal death. All the
5 babies born to mothers who took full course of FA were females.
Discussion
Our study in a population of pregnant Saudi women showed that
9.7% used FA supplementation beginning before and continuing after
conception (recommended periconceptional intake); this incidence is
low but comparable to the 6.8% incidence previously reported fromNo FA intake
(Group 3)a
Not sure about FA
(Group 4)a
Total
Number (%) Number (%) Number (%)
154 (6.3) 49 (2) 2441 (100)
31.7 ± 5.3 31.0 ± 5.3 29.9 ± 6.3
30.5–32.9 30.5–32.6 29.7–30.2
15–47 22–47 14–47
4.1 ± 3.2 3.2 ± 2.4 2.9 ± 2.6
3.6–4.6 2.5–3.9 2.8–3.0
0–13 0–10 0–16
153 (6.3) 46 (1.9) 2425 (99.3) b
29.3 ± 6.1 31.5 ± 7.5c 28.5 ± 6.0
28.3–30.3 29.3–33.7 28.2–28.7
18.1–50.1 15.4–56.6 14.0–56.6
sing the omnibus ANOVA methodology. It shows that the groups differ signiﬁcantly with
Table 2
Maternal social characteristics.
Full course FA
(Group 1)
Partial course FA
(Group 2)
No FA intake
(Group 3)
Not sure about FA
(Group 4)
p valuea
Number (%) Number (%) Number (%) Number (%)
Maternal education
Illiterate (no formal education) 49 (20.7) 594 (29.7) 60 (39.0) 20 (41.0) b0.0001
Elementary school graduate 90 (38.0) 718 (36.0) 42 (27.3) 9 (18.4)
Secondary school graduate 86 (36.3) 552 (27.6) 24 (15.6) 10 (20.4)
Tertiary (university graduate) 12 (5.1) 137 (6.8) 28 (18.2) 10 (20.4)
Total 237 (9.7) 2001 (82) 154 (6.3) 49 (2.0)
Maternal occupation
Housewife 167 (70.5) 1596 (79.8) 122 (79.2) 39 (79.6) b0.01
Teacher 38 (16.0) 198 (9.9) 20 (13.0) 5 (10.2)
Student 13 (5.5) 119 (5.9) 10 (6.5) 2 (4.1)
Other occupations 19 (8.0) 88 (4.4) 2 (1.3) 3 (6.1)
Total 237 (9.7) 2001 (82.0) 154 (6.3) 49 (2.0)
Monthly combined family income in Saudi riyals ($US)
b3000 (b800) 1 (0.4) 25 (1.2) 5 (3.2) 0 b0.0001
3000–6999 (800–1866) 48 (20.2) 438 (21.9) 31 (20.1) 6 (12.2)
7000–9999 (1867–2666) 74 (31.2) 729 (36.4) 53 (34.4) 8 (16.3)
10,000–14,999 (2667–3999) 55 (23.2) 417 (20.8) 36 (23.4) 5 (10.2)
≥15,000 (≥4000) 53 (22.4) 249 (12.4) 16 (10.4) 5 (10.2)
Unreported 6 (2.5) 143 (7.1) 13 (8.4) 25 (51.0)
Group mean income (mean ± SD) 11,098 ± 6594 9433 ± 4958 9767 ± 6645 9997 ± 4926
Total number of mothers in each group 237 2001 154 49
a The chi-square test of independence of the groups from the variables of interest (education, occupation, income).
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region: Lebanon 14.0% (Tamim et al., 2009), Abu-Dhabi in the United
Arab Emirates 7.8% (Al-Hassoni et al., 2010), and from Qatar and
Oman 13.2% (Hassan and Al-Kharusi, 2008). Nevertheless, it is lower
than the 32.0% incidence reported from Denmark (Hochberg and
Stone, 2014) and 39.0% reported from the Netherlands (EUROCAT folic
acid working group, 2009).
The 9.7% of periconceptional use of FA might reﬂect the low
awareness about the importance of FA intake in the Saudi society. A
study by Kari et al. (2008) reported that only 5.9% of female college
students in Jeddah (a major city in western Saudi Arabia) were aware
of the importance of receiving FA before and during pregnancy.
Mothers in group 2 (partial FA intake) represent 82% of our cohort
group; this substandard use of FA could be improved through better
education as reported by one author who showed that the higher the
education status of the women, the higher is her knowledge about the
beneﬁt and importance of FA (Al-Hakeem, 2012). In addition, thisTable 3
Main infant and maternal characteristics for the 49 babies born with NTDs grouped
according to the mother's FA intake.
Groups a
Characteristic Full course FA
N. (5)
Partial course FA
N. (38)
No FA intake
N. (6)
Baby
Male births, N (%) 0 (0) 14 (36.6) 4 (66.6)
Baby's birth weightb (kg)
mean ± SD
2.4 ± 0.4 2.3 ± 0.9 2.4 ± 1.1
Mother
Mother's age (yrs.), mean ± SD 30.0 ± 4.8 30.7 ± 6.0 35.6 ± 4.2
Illiteratec, N (%) 0 (0) 14 (36.6) 1 (16.6)
Housewives, N (%)d 2 (40) 32 (84.2) 1 (16.6)
First cousin's parents, N (%) 2 (40) 20 (52.6) 3 (50)
Multiparty ≥3, N (%) 2 (40) 21 (55.2) 4 (66.6)
Parity, mean ± SD 1.8 ± 1.6 2.9 ± 2.3 2.0 ± 1.5
N. = Number.
a Group 4was not included because therewere no cases of NTDs reported in this group.
b Mean baby's birth weight calculated for the live birth and stillbirth only.
c Illiterate mothers include mother who cannot read and write.
d Housewives mothers include mothers who do not work.could also be improved through planned pregnancies, as concluded by
Tekkesin and Taser (2012) from Istanbul, Turkey. These authors report-
ed a 100% periconceptional intake of FA among educated mothers
who had previously planned their pregnancies compared with 67%
of mothers who took FA periconceptionally following unplanned preg-
nancies, although they were at the same educated level. Over the last
50 years, Saudi society has undergone huge transformations because
of the oil boom resulting in improvements in education and socioeco-
nomic status of its citizens. This has led to the emergence of new mer-
chant families, and a large number of technocrats with smaller family
size among the new generations. Thus, a periconceptional intake of FA
and family planning of pregnancy are feasible and acceptable options
among the young Saudi and should be utilized.
In Saudi Arabia, it's mandatory for all couples to attend premarital
counseling clinics. In addition to meeting their primary goals (general
counseling, hepatitis B and HIV screening, sickle cell and thalassemia
carrier testing), the clinic personnel could also educate women about
the importance of periconceptional use of FA in preventing NTDs. Also,
closed circuit television programs in the obstetric outpatient clinics
can be used to educate illiterate women about the importance of FA
supplementation during the periconceptional period.
Although we agree with Al-Akhfash et al. (2013) that mothers with
higher levels of education have more knowledge of, and therefore
greater use of FA during the periconceptional period, these authors re-
ported that only 44/1000 (4.4%) Saudi mothers studied took FA before
pregnancy, which we believe, is an underestimation of the current
periconceptional use of FA by pregnant mothers in the kingdom of
Saudi Arabia. In addition, 68/1000 (6.8%) of their sampled mothers
took FA before pregnancy and during the ﬁrst trimester of pregnancy.
Thus an 11.2% of the mothers took supplemental FA at the proper
time (periconceptionally), which is closer to the 9.7% incidence that
we report here.
The prevalence of NTDs in our cohort was 1.7/1000 total births
(0.17%) and 0.90/1000 live births (0.09%). A 2011 study from our
institution had shown a NTD prevalence of 0.44/1000 live births. The
study also showed an increase in prevalence over 10 year period
(from 2001 to 2010) (Hakami and Majeed-Saidan, 2011). In our study,
the prevalence of NTDs is higher than the 0.94/1000 births reported
from the EUROCAT registries in Europe during the period 2004–2008
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pregnancy can reduce the prevalence of NTDs to approximately
0.5/1000 births (Berry et al., 1999; De Wals et al., 2008). Botto et al.
(2005) and Stoll et al. (2006) questioned the role of FA food fortiﬁcation
recommendation alone in preventing FA-preventable NTDs and sug-
gested new strategies need to be implemented to prevent NTDs.
Accordingly, mandatory FA fortiﬁcation of wheat ﬂour and other
grains including rice, a main staple food in Saudi Arabia, could reduce
the current prevalence of NTDs substantially. Until such policy is in
place for a few years, women of childbearing age should take the daily
recommended supplementation of FA (0.4 mg per day).
Among the 49 babies born with NTDs in our study, all (100%) from
mothers in group 1, and 24 of 38 (63.1%) from mothers in group 2
were females. This may indicate a selective gender protection in male
fetuses and needs further study because these numbers are too small
for a meaningful statistical analysis.
The Saudi women participating in this study were asked about their
FA supplementation use early in their current pregnancies. This
selection method differs from most other cross-sectional studies in
whichwomenwere asked about their FA intake long after their delivery.
Although Saudi women (dependent of military personnel) who were
involved in this study represent a special sector of the Saudi society,
we believe that the ﬁndings from this study may represent the actual
status of women in the entire country because the Saudi army recruits
personnel from various sectors of the Saudi society, although this
could represent a limitation to our study.
Conclusion
Our study found a higher prevalence of NTDs in Saudi Arabia than
from other industrialized countries, and highlights the need for a
national health education program to educate women of childbearing
age in high schools and colleges about the importance of receiving FA
before they become pregnant; we also highlight the need for a wider
implementation of mandatory FA fortiﬁcation of staple foods in Saudi
Arabia.
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